| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |